carvedilol has been researched along with Adjuvant Arthritis in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "3mg/kg) or carvedilol (10mg/kg) was administrated orally 1h before histamine injection into animals of a histamine-induced paw edema model and orally daily for 11days into animals of a formaldehyde-induced arthritis model." | 7.85 | Carvedilol can attenuate histamine-induced paw edema and formaldehyde-induced arthritis in rats without risk of gastric irritation. ( Kamel, MM; Labib, DA; Osman, AS, 2017) |
| "Carvedilol is an adrenergic antagonist which has been safely used in treatment of several cardiovascular disorders." | 5.39 | Carvedilol alleviates adjuvant-induced arthritis and subcutaneous air pouch edema: modulation of oxidative stress and inflammatory mediators. ( Arab, HH; El-Sawalhi, MM, 2013) |
| "3mg/kg) or carvedilol (10mg/kg) was administrated orally 1h before histamine injection into animals of a histamine-induced paw edema model and orally daily for 11days into animals of a formaldehyde-induced arthritis model." | 3.85 | Carvedilol can attenuate histamine-induced paw edema and formaldehyde-induced arthritis in rats without risk of gastric irritation. ( Kamel, MM; Labib, DA; Osman, AS, 2017) |
| "Carvedilol is an adrenergic antagonist which has been safely used in treatment of several cardiovascular disorders." | 1.39 | Carvedilol alleviates adjuvant-induced arthritis and subcutaneous air pouch edema: modulation of oxidative stress and inflammatory mediators. ( Arab, HH; El-Sawalhi, MM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osman, AS | 1 |
| Labib, DA | 1 |
| Kamel, MM | 1 |
| Eid, AH | 1 |
| Gad, AM | 1 |
| Fikry, EM | 1 |
| Arab, HH | 2 |
| Ahmed, YM | 1 |
| Messiha, BA | 1 |
| Abo-Saif, AA | 1 |
| El-Sawalhi, MM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy[NCT05553717] | 66 participants (Anticipated) | Interventional | 2022-10-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for carvedilol and Adjuvant Arthritis
| Article | Year |
|---|---|
Carvedilol can attenuate histamine-induced paw edema and formaldehyde-induced arthritis in rats without risk of gastric irritation.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Carbazoles; Carve | 2017 |
Venlafaxine and carvedilol ameliorate testicular impairment and disrupted spermatogenesis in rheumatoid arthritis by targeting AMPK/ERK and PI3K/AKT/mTOR pathways.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Apoptosis Regulatory Proteins; Arthritis, Experim | 2019 |
Granisetron and carvedilol can protect experimental rats againstadjuvant-induced arthritis.
Topics: Animals; Arthritis, Experimental; Biomarkers; Carbazoles; Cartilage Oligomeric Matrix Protein; Carve | 2017 |
Carvedilol alleviates adjuvant-induced arthritis and subcutaneous air pouch edema: modulation of oxidative stress and inflammatory mediators.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arthritis, Experimental; Carbazoles; Carvedilol; Ce | 2013 |